Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy Regimens in Node-Positive Breast Cancer (NSABP B-38)
NCT00093795Phase 3Completed
- Sponsor
- NSABP Foundation
- Start
- Oct 2004
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of gemcitabine in breast cancer (3 arms), sponsored by NSABP Foundation. Primary endpoint: Disease-free Survival at 5 years. Started Oct 2004; status: completed.
02
Drugs
gemcitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00093795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00093795.